AbbVie Inc (ABBV)
Working capital turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 56,334,000 | 54,318,000 | 58,054,000 | 56,197,000 | 45,804,000 |
| Total current assets | US$ in thousands | 25,582,000 | 33,002,000 | 28,463,000 | 27,928,000 | 24,173,000 |
| Total current liabilities | US$ in thousands | 38,749,000 | 37,841,000 | 29,538,000 | 35,194,000 | 28,661,000 |
| Working capital turnover | — | — | — | — | — |
December 31, 2024 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $56,334,000K ÷ ($25,582,000K – $38,749,000K)
= —
Based on the provided data, AbbVie Inc's working capital turnover ratio is not available for the years 2020 to 2024. The working capital turnover ratio is a measure of how effectively a company utilizes its working capital to generate sales revenue. Without specific values for this ratio over the years, it is not possible to evaluate AbbVie Inc's efficiency in managing its working capital to support its sales activities during the specified period. More detailed financial information or additional data points would be needed to provide a comprehensive analysis of AbbVie Inc's working capital turnover ratio.
Peer comparison
Dec 31, 2024